Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06410885 · ClinicalTrials.gov registry record · NA
Assessment of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device in Asymptomatic Patients
A NA study, sponsored by Rhaeos.
- Not yet
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06410885 is a NA study that has not yet begun recruiting, run by Rhaeos. The registered enrollment target is 60 participants.
The verdict
NCT06410885, a NA study, has not yet begun recruiting, sponsored by Rhaeos.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study evaluates the performance of the study device, FlowSense®, a sensor for non-invasively assessing cerebrospinal fluid (CSF) shunt flow. Subjects with an existing implanted ventricular CSF shunt will be evaluated with the study device in an outpatient setting to determine the negative predictive value (NPV; Part 1, blinded) and explore changes in surveillance imaging, health resource utilization, and visit duration during routine follow-up visits (Part 2, unblinded).
Interventions
- DEVICE Thermal Anisotropy Measurement Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-06 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06410885
The ClinicalTrials.gov registry entry for NCT06410885 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhaeos, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thermal Anisotropy Measurement Device is the first listed.
NCT06410885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06410885 about?
NCT06410885 is a clinical study titled "Assessment of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device in Asymptomatic Patients". This study evaluates the performance of the study device, FlowSense®, a sensor for non-invasively assessing cerebrospinal fluid (CSF) shunt flow. Subjects with an existing implanted ventricular CSF shunt will be evaluated with the study device in an outpatient setting to determine the negative predi...
What is the current status of trial NCT06410885?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-06. Estimated completion is 2026-05.
What interventions are being tested in trial NCT06410885?
The interventions under investigation include: Thermal Anisotropy Measurement Device (DEVICE).
Who is sponsoring clinical trial NCT06410885?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.